Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satyajit Kosuri

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
JAMA Oncology|November 6, 2025
Another Feather In The Cap for Posttransplant Cyclophosphamide GVHD Prophylaxis?Satyajit Kosuri, Chadi Nabhan
Leukemia & Lymphoma|January 30, 2014
Great expectations? Conditioning with busulfan, melphalan and thiotepa in recurrent Hodgkin lymphomaSatyajit Kosuri, Koen van Besien
Blood Advances|December 14, 2023
Utility or futility? A contemporary approach to allogeneic hematopoietic cell transplantation for TP53-mutated MDS/AMLMariam T Nawas, Satyajit Kosuri
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2018
Molecular Minimal Residual Disease Testing in Acute Myeloid Leukemia: A Review for the Practicing ClinicianAndrew Hantel, Wendy Stock, Satyajit Kosuri
Blood Reviews|September 4, 2021
Knowing the unknowns in high risk multiple myelomaBenjamin A Derman, Satyajit Kosuri, Andrzej Jakubowiak
Advances in Urology|June 14, 2012
Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapySatyajit Kosuri, Naveed H Akhtar, Michael Smith, et al.
Blood Advances|May 7, 2025
Intrathecal chemotherapy for ciltacabtagene autoleucel-associated movement and neurocognitive toxicityKaitlin Kelly, Jennifer Cooperrider, Michael R Bishop, et al.
Transplantation and Cellular Therapy|May 30, 2026
Outcomes and safety of CAR-T cell therapy in B-NHL patients with reduced left ventricular ejection fractionAlexandra E Rojek, Jia Guo, Justin Kline, et al.
Bone Marrow Transplantation|May 8, 2020
Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndromeJennifer H Cooperrider, Noreen Fulton, Andrew S Artz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2020
Unexpected Toxicities When Nivolumab Was Given as Maintenance Therapy following Allogeneic Stem Cell TransplantationAmy Y Wang, Justin Kline, Wendy Stock, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
JAMA Oncology|November 6, 2025
Another Feather In The Cap for Posttransplant Cyclophosphamide GVHD Prophylaxis?Satyajit Kosuri, Chadi Nabhan
Leukemia & Lymphoma|January 30, 2014
Great expectations? Conditioning with busulfan, melphalan and thiotepa in recurrent Hodgkin lymphomaSatyajit Kosuri, Koen van Besien
Blood Advances|December 14, 2023
Utility or futility? A contemporary approach to allogeneic hematopoietic cell transplantation for TP53-mutated MDS/AMLMariam T Nawas, Satyajit Kosuri
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2018
Molecular Minimal Residual Disease Testing in Acute Myeloid Leukemia: A Review for the Practicing ClinicianAndrew Hantel, Wendy Stock, Satyajit Kosuri
Blood Reviews|September 4, 2021
Knowing the unknowns in high risk multiple myelomaBenjamin A Derman, Satyajit Kosuri, Andrzej Jakubowiak
Advances in Urology|June 14, 2012
Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapySatyajit Kosuri, Naveed H Akhtar, Michael Smith, et al.
Blood Advances|May 7, 2025
Intrathecal chemotherapy for ciltacabtagene autoleucel-associated movement and neurocognitive toxicityKaitlin Kelly, Jennifer Cooperrider, Michael R Bishop, et al.
Transplantation and Cellular Therapy|May 30, 2026
Outcomes and safety of CAR-T cell therapy in B-NHL patients with reduced left ventricular ejection fractionAlexandra E Rojek, Jia Guo, Justin Kline, et al.
Bone Marrow Transplantation|May 8, 2020
Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndromeJennifer H Cooperrider, Noreen Fulton, Andrew S Artz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2020
Unexpected Toxicities When Nivolumab Was Given as Maintenance Therapy following Allogeneic Stem Cell TransplantationAmy Y Wang, Justin Kline, Wendy Stock, et al.
Pageof 5